Evaluating the Safety of Maribavir for the Treatment of Cytomegalovirus
Ronak G Gandhi,1 Camille N Kotton2 1Department of Pharmacy, Massachusetts General Hospital, Boston, MA, USA; 2Infectious Diseases Division, Massachusetts General Hospital, Boston, MA, USACorrespondence: Ronak G Gandhi, Senior Attending Pharmacist – Infectious Diseases, Department of Pharmacy, Massac...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Dove Medical Press
2022-03-01
|
| Edice: | Therapeutics and Clinical Risk Management |
| Témata: | |
| On-line přístup: | https://www.dovepress.com/evaluating-the-safety-of-maribavir-for-the-treatment-of-cytomegaloviru-peer-reviewed-fulltext-article-TCRM |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|